What is The Prostate Protocol? The Prostate Protocol by Scott Davis is an eBook program that provides alternative treatment for Benign Prostatic Hyperplasia [BPH] or an enlarged prostate. This guide ...

Benign Prostatic Hyperplasia (BPH) is defined as an enlarged prostate that affects millions of men worldwide. According to Scott Davis, the maker of The Prostate Protocol, modern living, which ...

Treating an aggressive disease is always challenging but improving the way therapies are applied can benefit patients by giving them a better outcome. In a new study published by European Urology, ...

A new three-phase screening protocol that incorporates a PSA test, a four-kallikrein panel, and an MRI scan appears to improve the prostate cancer detection rate among men invited to participate in a ...

Sexual Function Retained in Prostate Cancer Combination Therapy Researchers compared targeted prostate biopsy based on biparametric magnetic resonance imaging with standard 12-core systematic biopsy.

Protocol-directed prostate cancer active surveillance offers acceptable oncologic safety. Protocol-directed active surveillance of localized prostate cancer reduces unnecessary treatment of men ...

Although sextant biopsies of the prostate have become the standard technique for the investigation of raised PSA levels, cancer in the lateral and peripheral zones of the prostate might not be ...

Prostate cancer patients with T2c-T4 prostate cancer with no extra pelvic lymph node involvement and prostate-specific antigen (PSA) less than 150 ng/mL were included. All patients received 4 months ...

Incidence of hypocalcemia in patients with castration-resistant prostate cancer treated with denosumab: Data from a non-inferiority phase III trial assessing prevention of symptomatic skeletal events ...

Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.

NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced amendments to the protocols for two ...